While we always personalize treatment, heres a general starting point we use when creating a plan: Dosage: 250 to 500 mcg per day Method: Subcutaneous injection near the affected joint Cycle: 4 weeks on, followed by 2 to 4 weeks off Duration: Usually 1 to 3 cycles, depending on severity Injectable BPC-157 is preferred for arthritis
Chemical probes for molecular imaging and detection of hydrogen sulfide and reactive sulfur species in biological systems
Allow peptide and bacteriostatic water vials to reach room temperature (~30 minutes) to avoid thermal shock
Because the BPC-157 peptide operates through VEGFR2 and NO pathways that are mechanistically distinct from TB-500s actin-based signaling and GHK-Cus collagen synthesis mechanisms, the three compounds address complementary aspects of tissue repair without documented antagonism in animal studies
1Pharmacokinetic and pharmacodynamic studies with CJC-1295, a long-acting growth hormone releasing peptidePubMed / Journal of Clinical Endocrinology & Metabolism 2006 2Ipamorelin, the first selective growth hormone secretagoguePubMed / European Journal of Endocrinology 2001